Neogenomicsinc. buy melinda
Start price
26.11.17
/
50%
€9.24
Target price
20.02.18
€10.00
Performance (%)
-18.83%
End price
20.02.18
€7.50
Summary
This prediction ended on 20.02.18 with a price of €7.50. The price of Neogenomicsinc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -18.83%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Neogenomicsinc. | -4.380% | -4.380% | -18.634% | -61.047% |
iShares Core DAX® | -0.683% | 1.890% | 15.367% | 17.155% |
iShares Nasdaq 100 | 0.335% | 4.631% | 29.818% | 56.187% |
iShares Nikkei 225® | -1.486% | -2.361% | 7.668% | 3.633% |
iShares S&P 500 | -0.523% | 2.324% | 25.460% | 46.452% |
Comments by melinda for this prediction
In the thread Neogenomicsinc. diskutieren
NeoGenomics, Inc. Bietet Krebsdiagnostik und Pharma services.It betreibt über ein Netzwerk von Krebs Focused Prüflaboratorien genetischer und molekularer zur Bereitstellung von Test services.It bietet verschiedene Test - Dienstleistungen, einschließlich Zytogenetik, Fluoreszenz - In-Situ - Hybridisierung, Durchflusszytometrie,
(Vom Mitglied beendet)